NEXGEL, Inc. (NXGL)

NASDAQ: NXGL · Real-Time Price · USD
2.180
-0.030 (-1.36%)
May 30, 2025, 1:01 PM - Market open
-1.36%
Market Cap 16.69M
Revenue (ttm) 10.23M
Net Income (ttm) -3.14M
Shares Out 7.65M
EPS (ttm) -0.45
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 21,780
Open 2.255
Previous Close 2.210
Day's Range 2.160 - 2.260
52-Week Range 1.840 - 5.100
Beta 0.65
Analysts n/a
Price Target n/a
Earnings Date May 13, 2025

About NXGL

NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure ... [Read more]

Sector Healthcare
IPO Date Dec 22, 2021
Employees 19
Stock Exchange NASDAQ
Ticker Symbol NXGL
Full Company Profile

Financial Performance

In 2024, NEXGEL's revenue was $8.69 million, an increase of 112.47% compared to the previous year's $4.09 million. Losses were -$3.28 million, 3.93% more than in 2023.

Financial Statements

News

NEXGEL, Inc. (NXGL) Q1 2025 Earnings Call Transcript

NEXGEL, Inc. (NASDAQ:NXGL) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Company Participants Valter Pinto - Managing Director of KCSA Strategic Communications Adam Levy - Chief Executive ...

16 days ago - Seeking Alpha

NEXGEL to Report First Quarter 2025 Financial Results on May 13th

Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa.

21 days ago - GlobeNewsWire

NEXGEL, Inc. (NXGL) Q4 2024 Earnings Call Transcript

NEXGEL, Inc. (NASDAQ:NXGL) Q4 2024 Earnings Conference Call March 24, 2025 4:30 PM ET Company Participants Valter Pinto - Managing Director of KCSA Strategic Communications Adam Levy - Chief Executiv...

2 months ago - Seeking Alpha

NEXGEL Reports Record Fourth Quarter and Full Year 2024 Financial Results

Fourth quarter 2024 revenue totaled $3.04 million, an increase of 181%, as compared to $1.08 million for the same period the prior year

2 months ago - GlobeNewsWire

NEXGEL to Report Fourth Quarter and Full Year 2024 Financial Results on March 24th

Management will host a conference call at 4:30 p.m. ET on the same day LANGHORNE, Pa.

2 months ago - GlobeNewsWire

NEXGEL to Participate in Webull Consumer Virtual Webinar on February 18, 2025

LANGHORNE, Pa., Feb. 13, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, h...

3 months ago - GlobeNewsWire

NEXGEL Appoints Joseph F. McGuire as Chief Financial Officer

LANGHORNE, Pa., Jan. 02, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, h...

5 months ago - GlobeNewsWire

NEXGEL, Inc. (NXGL) Q3 2024 Earnings Call Transcript

NEXGEL, Inc. (NASDAQ:NXGL) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Company Participants Maria Honeycutt - Account Director of KCSA Strategic Communications Adam Levy - Chief Exe...

7 months ago - Seeking Alpha

NEXGEL Reports Record Third Quarter 2024 Revenue of $2.94 Million, an Increase of 141% Year-Over-Year and 104% Sequentially

Quarterly revenue growth driven by a sequential increase of 99% in branded consumer products and 103% in contract manufacturing

7 months ago - GlobeNewsWire

NEXGEL Announces $2,000,000 Registered Direct Offering

LANGHORNE, Pa., Nov. 11, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, hig...

7 months ago - GlobeNewsWire

NEXGEL to Participate in Upcoming October Investor Conferences

LANGHORNE, Pa., Oct. 11, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, h...

8 months ago - GlobeNewsWire

NEXGEL Appoints Kip Crecca to its Scientific Advisory Board

LANGHORNE, Pa., Oct. 04, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, h...

8 months ago - GlobeNewsWire

NEXGEL, Inc. (NXGL) Q2 2024 Earnings Call Transcript

NEXGEL, Inc. (NASDAQ:NXGL) Q2 2024 Earnings Conference Call August 14, 2024 4:30 PM ET Company Participants Valter Pinto - Managing Director of KCSA Strategic Communications Adam Levy - Chief Executi...

10 months ago - Seeking Alpha

NEXGEL Reports Record Second Quarter 2024 Revenue of $1.44 Million

LANGHORNE, Pa., Aug. 14, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and...

10 months ago - GlobeNewsWire

NEXGEL to Report Second Quarter 2024 Financial Results on August 14th

Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa.

10 months ago - GlobeNewsWire

NEXGEL and Innovative Optics US Initiate Institutional Review Board (IRB) Study in Accordance with FDA of Hydrogel Application During Laser Hair Removal

The 30-patient study is designed to measure the efficacy of applying NEXGEL's hydrogel during laser hair removal in eliminating harmful particles or plume during treatments

11 months ago - GlobeNewsWire

NEXGEL Announces Preliminary Record Second Quarter 2024 Revenue of $1.4 Million and Issues Revenue Guidance for Third and Fourth Quarter of 2024 of $2.2 Million and $2.6 Million, Respectively

LANGHORNE, Pa., July 08, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, hig...

11 months ago - GlobeNewsWire

NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North America

LANGHORNE, Pa., June 11, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, hig...

1 year ago - GlobeNewsWire

NEXGEL Acquires International Beauty Brand, Silly George

Acquisition further expands NEXGEL Health, Wellness, and Beauty consumer product portfolio Silly George is on a revenue run rate of approximately $2 million LANGHORNE, Pa., May 16, 2024 (GLOBE NEWSWIR...

1 year ago - GlobeNewsWire

NEXGEL, Inc. (NXGL) Q1 2024 Earnings Call Transcript

NEXGEL, Inc. (NASDAQ:NXGL) Q1 2024 Results Conference Call May 13, 2024 4:30 PM ET Company Participants Valter Pinto - Managing Director, KCSA Strategic Communications Adam Levy - Chief Executive Off...

1 year ago - Seeking Alpha

NEXGEL, Inc. (NXGL) Q4 2023 Earnings Call Transcript

NEXGEL, Inc. (NXGL) Q4 2023 Earnings Call Transcript

1 year ago - Seeking Alpha

NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year

LANGHORNE, Pa., April 01, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare an...

1 year ago - GlobeNewsWire

NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday

LANGHORNE, Pa., March 27, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, ...

1 year ago - GlobeNewsWire

NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th

Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa.

1 year ago - GlobeNewsWire

NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th

LANGHORNE, Pa., March 04, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, ...

1 year ago - GlobeNewsWire